Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
Allergan
Patricia Pozo-Rosich; Jessica Ailani; Messoud Ashina; Peter J Goadsby; Richard B Lipton; Uwe Reuter; Hua Guo; Brittany Schwefel; Kaifeng Lu; Ramesh Boinpally; Rosa Miceli; Rosa De Abreu Ferreira; Emily McCusker; Sung Yun Yu; Lawrence Severt; Michelle Finnegan; Joel M Trugman